Natixis Advisors
TMDX icon

Natixis Advisors’s Transmedics TMDX Stock Holding History

Natixis Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,220
Closed -$1.02M – 1869
2026
Q1 		$1.02M Sell
10,220
-1,803
-15% -$235K ﹤0.01% 1351
2025
Q4 		$1.46M Sell
12,023
-1,259
-9% -$158K ﹤0.01% 1145
2025
Q3 		$1.49M Sell
13,282
-1,533
-10% -$179K ﹤0.01% 1193
2025
Q2 		$1.99M Buy
+14,815
New +$1.63M ﹤0.01% 1084
2025
Q1 		– Sell
-62,687
Closed -$3.91M – 1682
2024
Q4 		$3.91M Sell
62,687
-15,386
-20% -$1.43M 0.01% 890
2024
Q3 		$12.3M Buy
78,073
+17,933
+30% +$2.76M 0.02% 603
2024
Q2 		$9.06M Buy
+60,140
New +$7.21M 0.02% 637

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Natixis Advisors's TMDX Position: Q2 2026 in Review

Natixis Advisors sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 10,220 shares — an estimated $1.02M sold.

Natixis Advisors first reported a position in TMDX in Q2 2024 and held it in 7 quarters. The position peaked at $12.3M in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Natixis Advisors reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Natixis Advisors sold 10,220 Transmedics shares in Q2 2026, an estimated $1.02M.
  • Natixis Advisors first reported a position in Transmedics in Q2 2024 and held it in 7 quarters.
  • Natixis Advisors's Transmedics position peaked at $12.3M in Q3 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.